David M. Cote


David M. “Dave” Cote is an American businessman. Cote previously worked for General Electric and TRW Inc. before he was appointed chairman and chief executive officer of Honeywell in 2002, following their acquisition by AlliedSignal. Cote also sat on the JP Morgan Chase risk committee during the period in which the firm lost $6 billion trading credit derivatives. Cote stepped down as CEO at Honeywell at the end of March 2017 and was succeeded by Darius Adamczyk.

David M. Cote

What is ‘David M. Cote’

The CEO and chairman and former president of Honeywell International. Cote achieved these positions in 2002, and since then has dealt with asbestos lawsuits, company debt and falling stock prices. He helped Honeywell improve its manufacturing processes and improve its financial position by increasing sales, earnings per share and cash flow. He holds a bachelor’s degree from the University of New Hampshire and has also served on the board of JP Morgan Chase.

Explaining ‘David M. Cote’

Born in 1952, Cote began his career with General Electric in 1974 as a factory laborer and worked his way up to president and CEO of appliances by helping the company cut costs and increase sales, especially in Asia. He joined TRW in 1999 and became its president, CEO and chairman and helped the company improve its manufacturing processes and create a subsidiary, Velocium.

Further Reading

  • The convention on biological diversity's 2010 target – science.sciencemag.org [PDF]
  • Familiarity bias and perceived future home price movements – www.tandfonline.com [PDF]
  • Chronic obstructive pulmonary disease and asthma–patient characteristics and health impairment – www.tandfonline.com [PDF]
  • Ten-year outcomes following traumatic brain injury: a population-based cohort – www.tandfonline.com [PDF]
  • Exercise testing in severe emphysema: association with quality of life and lung function – www.tandfonline.com [PDF]
  • Penile cancer and human papilloma virus (HPV) in a human immunodeficiency virus (HIV)-infected patient – www.tandfonline.com [PDF]
  • Imatinib mesylate lacks efficacy in relapsed/refractory peripheral T cell lymphoma – www.tandfonline.com [PDF]
  • Utopian pedagogy: Creating radical alternatives in the neoliberal age – www.tandfonline.com [PDF]
  • Effect of financial development on economic growth in sub-Saharan Africa – www.sciencedirect.com [PDF]
  • Climate change, coral loss, and the curious case of the parrotfish paradigm: Why don't marine protected areas improve reef resilience? – www.annualreviews.org [PDF]